Information Library

Results for: Faster product development - Clinical Services - Phase II/III

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • A Focus on CNS

    Brochure — July 1, 2011
    Quintiles is your ally for broad and deep CNS expertise in every aspect of the drug development process.

  • The Molecular Biomarker Revolution in Non-Small Cell Lung Cancer

    White Paper — June 23, 2011
    In this new white paper Quintiles’ experts Christopher Ung, Jason Hill, Carrie Lee and Harish Dave review some of the most promising molecular pathways and targeted approaches for NSCLC, the critical role of diagnostics, and strategies to detect and address the emergence of resistance.

  • KoNECT & Quintiles Partner to Advance Clinical Research

    Press Release — May 30, 2011 – The Korea National Enterprise for Clinical Trials (KoNECT) and Quintiles have partnered to produce educational events in South Korea for investigators and biopharmaceutical companies.

  • Biomarkers in Alzheimers Disease

    Presentation — March 17, 2011
    The Quintiles Innovation Unit shares their knowledge on the use of biomarkers in compound development in clinical trials.

  • Clinical – Smarter Trials, Accelerated Outcomes

    Brochure — February 16, 2011
    Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues.

  • Exclusive Report From Scientific American

    Hear from the Experts — November 9, 2010
    In-depth insights on every angle of the changing health landscape - brought to you by Quintiles Get the report today.

  • Oncology Drug Development and Value-Based Medicine

    White Paper — November 5, 2010
    This report demonstrates the need to converge clinical and commercial imperatives earlier within the drug development process to meet a future demand for value-based medical practices.

  • Pharmacobiomics and Infectious Disease: Progress and Opportunities

    White Paper — November 2, 2010
    Pharmacobiomics and Infectious Disease: Progress Opportunities. After decades of work mapping the human genome, we are beginning to reap real benefits.

  • From Biomarkers to Diagnostics - The Road to Success

    White Paper — October 18, 2010
    In the second installment of a two-part series, Eric Groves, Jason Hill and Christopher Ung walk through the challenges associated with drug-diagnostic co-development, addressing potential pitfalls and areas of opportunity.

  • Advancing Clinical Research in Alzheimer's Disease

    White Paper — October 18, 2010
    This report from Quintiles’ own Alzheimer’s experts gives you an inside look at the news from ICAD 2010.

Page 1 of 5 (43 results)

Subscribe to Email Based on Your Interests

Set preferences